Post-COVID-19 Hyperglycemia: A Concern in Selection of Therapeutic Regimens

نویسندگان
Negahdaripour, Manica ID 1

1 Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran;

doi
10.30476/ijms.2021.47666
چکیده

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an RNA betacoronavirus responsible for coronavirus disease 2019 (COVID-19), has already caused nearly four million deaths around the world according to the WHO data. 

کلیدواژه‌ها
COVID-19, Hyperglycemia, Therapeutic Regimens